NorthCrest Asset Manangement, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1893159 PLYMOUTH, MN

Position in VRTX

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$771,918

+$300,372 QoQ

Shares Held

1,554

+47.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#140

of 331 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 47% Shared 0% None 53%

Healthcare · as of Jun 30, 2026

NorthCrest Asset Manangement, LLC holds $17,717,995 across 23 Biotechnology names. VRTX ranks #6 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	9,963	$6,212,329
2	HALO	Halozyme Therapeutics, Inc.	45,150	$3,533,890
3	EXEL	Exelixis, Inc.	28,794	$1,566,681
4	INCY	Incyte Corp	12,026	$1,363,267
5	TGTX	Tg Therapeutics, Inc.	15,378	$844,867
6	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,554	$771,918
7	MIRM	Mirum Pharmaceuticals, Inc.	5,414	$633,816
8	BMRN	Biomarin Pharmaceutical Inc	7,974	$456,272

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$771,918	1,554	+47.2%	Shares	Sole	2026-07-15
2026-03-31	$471,546	1,056	-3.6%	Shares	Sole	2026-04-08
2025-12-31	$496,429	1,095	-19.8%	Shares	Sole	2026-01-08
2025-09-30	$534,980	1,366	-1.0%	Shares	Sole	2025-10-29
2025-06-30	$614,376	1,380	-0.6%	Shares	Sole	2025-07-10
2025-03-31	$673,414	1,389	+7.4%	Shares	Sole	2025-04-16
2024-12-31	$520,691	1,293	-8.8%	Shares	Sole	2025-03-17
2024-09-30	$659,483	1,418	+15.3%	Shares	Sole	2024-10-24
2024-06-30	$576,525	1,230	+31.4%	Shares	Sole	2024-07-16
2024-03-31	$391,257	936	+12.9%	Shares	Sole	2024-04-15
2023-12-31	$337,311	829	-35.2%	Shares	Sole	2024-01-30
2023-09-30	$445,107	1,280	-1.1%	Shares	Sole	2023-11-13
2023-06-30	$455,371	1,294	+0.5%	Shares	Sole	2023-07-21
2023-03-31	$405,810	1,288	-1.8%	Shares	Sole	2023-04-25
2022-12-31	$378,590	1,311	—	Shares	Sole	2023-02-01
No filing history on record for this holder in this stock.